María
Díez Campelo
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2017
-
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts
Leukemia Research, Vol. 56, pp. 82-87
2016
-
Chromothripsis is a recurrent genomic abnormality in high-risk myelodysplastic syndromes
PLoS ONE, Vol. 11, Núm. 10